NCT04826744 Frequency of Palpebral Involvement in Adult With Atopic Dermatitis
| NCT ID | NCT04826744 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Lille |
| Condition | Atopic Dermatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 550 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 550 participants in total. It began in 2021-09-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Atopic dermatitis is a common inflammatory skin disease, resulting from genetical, immunological and environmental factors. Head and neck are among the most frequent involved areas, almost 50% in adult patients according to most publications. Palpebral involvement is also common and a source of major quality of life impairment for patients. However, the real frequency of this palpebral involvement is unknown, only estimated about 20% in few studies. The treatment of this location remains difficult, regarding to the thickness of palpebral skin and proximity of the eye. To our knowledge, no prospective studies about allergological skin tests (such as patch-tests) in atopic patients with palpebral involvement had been conducted. Finally, atopic dermatitis is frequently associated with ophthalmological diseases such as conjunctivitis, keratoconus or cataract, which belong to the minor criteria of Hanifin and Rakja classification. A better knowledge of the atopic dermatitis palpebral involvement and the associated factors seems to be needed to improve the treatment and the quality of life of patients
Eligibility Criteria
Inclusion Criteria: * Atopic Dermatitis according to the revised Hanifin and Rakja criteria (UK Working Party) * Oral consent * Valid social insurance Exclusion Criteria: * Personal history of uncontrolled asthma * No social insurance * Protective measures * Age under 18 * Pregnancy or breast-feeding
Contact & Investigator
Delphine Staumont-Salle, MD,PhD
PRINCIPAL INVESTIGATOR
University Hospital, Lille
Frequently Asked Questions
Who can join the NCT04826744 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atopic Dermatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04826744 currently recruiting?
Yes, NCT04826744 is actively recruiting participants. Contact the research team at delphine.salle@chru-lille.fr for enrollment information.
Where is the NCT04826744 trial being conducted?
This trial is being conducted at Lille, France, Rouen, France.
Who is sponsoring the NCT04826744 clinical trial?
NCT04826744 is sponsored by University Hospital, Lille. The principal investigator is Delphine Staumont-Salle, MD,PhD at University Hospital, Lille. The trial plans to enroll 550 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.